Endometriosis
Conditions
Interventions
Participants will be randomly allocated into 2 groups (n = 30) via a computer system maintaining confidentiality with opaque, sealed and numbered envelopes. Control Group (CG): volunteers will undergo
Sponsors
Universidade Brasil
Universidade Brasil
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Women with Endometriosis with laboratory diagnosis; age group between 20 and 50 years; ability to respond to questionnaires; ability to consent to participation in the study and sign informed consent
Exclusion criteria
Exclusion criteria: Volunteers with a history of hysterectomy or oophorectomy; pregnant or breastfeeding women; BMI greater than 30kg/m2 have a history of previous physical abdominal trauma in the last 3 months; use of psychotropic medications; infectious diseases (tuberculosis, leprosy, HIV, systemic fungal diseases) or any other similar condition; severe underlying disease (heart, kidney, liver, lung) or malignancy; diabetes mellitus and decompensated hyperthyroidism; history of topical and aesthetic treatments in the last 3 months; glucose 6-phosphate deficiency; lack of ability or willingness to provide informed consent; lack of availability for visits or to comply with study procedures; hypersensitivity to ozone therapy treatment, climacteric or premature ovarian failure; pelvic pain complaints; use of oral or injectable hormonal contraceptives; progestogens
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate pain during the 10 weeks of treatment and for 60 days after the applications, verified by the Visual Analog Scale screening. This performance is expected to assess whether there has been a reduction in pain based on the verification of a variation of at least 2 points in pre- and post-intervention follow-ups | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate sexual function and quality of life during the 10 weeks of treatment and for 60 days after the applications, verified by the Endometriosis Health Profile Questionnaire (EHP-30). It is expected to evaluate the improvement or not of the patient's sexual function and quality of life from the verification of a variation of at least 2 points of pre- and post-intervention measurements.;Evaluate the anxiety and the level of depression during the 10 weeks of treatment and for 60 days after the applications, verified by the Beck Hopelessness Scale and sessions of dealing with”, “overcoming”, “coping”, “taking care of”, “ endure” (short COPE). It is expected to evaluate the level of anxiety and the level of depression from the verification of a variation of at least 2 points of exercises pre and post-intervention. | — |
Countries
Brazil
Contacts
Public ContactJynani Morais
Universidade Brasil
Outcome results
None listed